FDA advisory panel set to review Moderna, Pfizer vaccines for kids under 5

FDA advisory panel set to review Moderna, Pfizer vaccines for kids under 5

The Food and Drug Administration’s advisory committee will meet today to vote on whether or not to approve the COVID-19 vaccine for children as young as 6 months old.